Prior evidence of human use
Freedom is developing a combination drug product consisting of Ketamine and a complementary molecule whose long-term treatment effect is expected to be nearly 2.5X that of Ketamine alone. Freedom was spun out of Yale by its cofounder Dr. John Krystal, the chair of psychiatry at Yale and one of the original discoverers of Ketamine’s therapeutic potential.
Under the radar for now - more info soon.
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance
